tyrosine has been researched along with Cicatrix, Hypertrophic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carney, BC; Collins, M; Keyloun, JW; Kurup, S; Moffatt, LT; Oliver, MA; Shupp, JW; Travis, TE | 1 |
| Chen, XL; Cheng, T; Chu, TG; Gao, WY; Jiang, LF; Li, XY; Li, ZJ; Pan, H; Yang, JQ; Yi, CG; Yu, Q; Zhang, GY; Zheng, MH; Zhou, FY | 1 |
2 other study(ies) available for tyrosine and Cicatrix, Hypertrophic
| Article | Year |
|---|---|
Laser-assisted drug delivery of synthetic alpha melanocyte stimulating hormone and L-tyrosine leads to increased pigmentation area and expression of melanogenesis genes in a porcine hypertrophic scar model.
Topics: alpha-MSH; Animals; Cicatrix, Hypertrophic; Hyperpigmentation; Hypopigmentation; Lasers, Gas; Melanins; Pharmaceutical Preparations; Pigmentation; Swine; Tyrosine | 2023 |
Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.
Topics: Cell Growth Processes; Cells, Cultured; Cicatrix, Hypertrophic; Connective Tissue; Connective Tissue Growth Factor; Dose-Response Relationship, Immunologic; Extracellular Matrix; Fibroblasts; Humans; Oxazoles; PPAR gamma; Prostaglandin D2; Transcriptional Activation; Transforming Growth Factor beta; Tyrosine | 2009 |